Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: XERS) | Delayed: 10.17 -0.54 (5.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.71 | 52 Week High | $ | |||
| Open | $10.71 | 52 Week Low | $ | |||
| Day High | $10.72 | P/E | N/A | |||
| Day Low | $10.08 | EPS | $ | |||
| Volume | 2,309,307 | |||||
